Literature DB >> 28733756

Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Güneş Altıokka-Uzun1, Ece Erdağ2, Betül Baykan3, John Tzartos4,5, Duygu Gezen-Ak6, Bedia Samancı3, Erdinç Dursun6, Paraskevi Zisimopoulou4, Katerina Karagiorgou4, Christos Stergiou4, Erdi Şahin3, Esme Ekizoğlu3, Murat Kürtüncü3, Erdem Tüzün2.   

Abstract

Headache and visual disturbances are the main presenting symptoms of idiopathic intracranial hypertension (IIH) characterized by increased intracranial pressure (ICP) with an unknown cause. We aimed to investigate the antibodies against optic neuritis-associated glial antigens, aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) and uncharacterized neuronal membrane antigens in IIH patients. Consecutive patients diagnosed according to Friedman revised diagnostic criteria and control subjects were included after their consent. All serum samples were analyzed for antibodies against AQP4 and MOG using cell-based immunofluorescent assays and for uncharacterized neuronal membrane antigens by indirect immunocytochemistry utilizing live neurons. Sera of 34 patients with IIH and 40 control subjects were investigated but none of the patients showed AQP4 and MOG antibodies. However, serum IgG of five IIH patients showed reactivity against membrane antigens of rat hippocampal and cortical neurons. Interestingly, three out of these five patients had nonspecific white matter lesions on MRI, whereas only four of all other patients had these lesions (p = 0.048). AQP4 and MOG antibodies do not seem to have a role in the pathophysiology of IIH. However, association of immunocytochemistry findings with the presence of white matter lesions may suggest that immunological factors contribute to the pathogenesis of IIH in at least some of the patients.

Entities:  

Keywords:  Aquaporin-4; Idiopathic intracranial hypertension; Immunocytochemistry; Myelin oligodendrocyte glycoprotein; Pathophysiology; Vision loss

Mesh:

Substances:

Year:  2017        PMID: 28733756     DOI: 10.1007/s10072-017-3066-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

Review 1.  The molecular basis of water transport in the brain.

Authors:  Mahmood Amiry-Moghaddam; Ole P Ottersen
Journal:  Nat Rev Neurosci       Date:  2003-12       Impact factor: 34.870

2.  Idiopathic intracranial hypertension.

Authors:  Alex J Sinclair; Rebecca Woolley; Susan P Mollan
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

3.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

4.  Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Authors:  Kathrin Doppler; Morten Schütt; Claudia Sommer
Journal:  Cephalalgia       Date:  2016-02-06       Impact factor: 6.292

5.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

6.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

7.  Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema.

Authors:  Marios C Papadopoulos; Geoffrey T Manley; Sanjeev Krishna; A S Verkman
Journal:  FASEB J       Date:  2004-06-18       Impact factor: 5.191

Review 8.  Aquaporins: role in cerebral edema and brain water balance.

Authors:  Zsolt Zador; Orin Bloch; Xiaoming Yao; Geoffrey T Manley
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

Review 9.  Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.

Authors:  Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Autoimmun Rev       Date:  2015-12-17       Impact factor: 9.754

Review 10.  Idiopathic intracranial hypertension.

Authors:  B R Wakerley; M H Tan; E Y Ting
Journal:  Cephalalgia       Date:  2014-05-20       Impact factor: 6.292

View more
  3 in total

1.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension: A Case Report.

Authors:  Jaydip Ray Chaudhuri; Jui Jade Bagul; Alluri Swathi; Bhim Sen Singhal; N Chakradhar Reddy; Kiran Kumar Vallam
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-10-19

2.  Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination.

Authors:  Lina Jeantin; Adèle Hesters; Dorine Fournier; Bénédicte Lebrun-Vignes; Aurélie Méneret; Caroline Papeix; Valérie Touitou; Elisabeth Maillart
Journal:  J Neurol       Date:  2022-04-23       Impact factor: 6.682

3.  Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin.

Authors:  Erdinç Dursun; Duygu Gezen-Ak
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.